We recently developed a patent assay named QuantiDNA™ that is an extremely sensitive and precise assay for measuring DNA released into the circulation after
whole body radiation exposure.

Our QuantiDNA™ detection kit is the only bioassay in the market to monitor cancer
IR treatment. This product is also the only a biodosimeter assay to detect damage from manmade or naturally occurring threats (radiation).

We have accumulated years of experience in the design, manufacture and supply of state of the art detection systems to continuously monitor levels of manmade or naturally occurring threats.

For over a decade the company has worked closely with the Defence Department in the development of its technology, and in July 2007 formed Company for the development and manufacture of defence-critical reagents.